Tepezza is an FDA-approved medication used to treat thyroid eye disease (TED), effectively reducing visible symptoms such as bulging eyes, eye misalignment, pain, redness, and double or blurry vision. Patients often see significant improvement in eye bulging and related symptoms after a series of Tepezza infusions over approximately 24 weeks. Many patients notice changes as early as six weeks into treatment, and results can include reduced eye protrusion, improved eyelid function, and a return of normal appearance and comfort. Before treatment, patients with TED commonly experience bulging eyes, redness, pain, double vision, eyelid closure difficulties, and discomfort. After completing a full course of Tepezza infusions, many patients report decreased bulging by about 2 to 3 millimeters, reduced symptoms like tightness and irritation, improved eye movement, and an enhanced quality of life with restored confidence in appearance. Real patient testimonials and clinical studies show Tepezza can reverse or significantly improve TED symptoms, even in cases where surgery or previous treatments were insufficient. Side effects exist, including muscle cramps, nausea, hair loss, and changes in blood sugar, but many find the benefits outweigh these concerns. Visual before-and-after comparisons often reveal marked reduction in eye protrusion and inflammation, with many patients experiencing less eye discomfort and improved vision post- treatment.
